Arvest Bank Trust Division Buys New Stake in Healthpeak Properties, Inc. $DOC

Arvest Bank Trust Division purchased a new position in Healthpeak Properties, Inc. (NYSE:DOC) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 36,227 shares of the real estate investment trust’s stock, valued at approximately $583,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in DOC. Integrated Wealth Concepts LLC raised its holdings in shares of Healthpeak Properties by 7.3% in the first quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after buying an additional 1,231 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Healthpeak Properties by 110.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock worth $2,463,000 after buying an additional 63,930 shares during the last quarter. Woodline Partners LP raised its holdings in shares of Healthpeak Properties by 41.3% in the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock worth $1,195,000 after buying an additional 17,279 shares during the last quarter. Brown Advisory Inc. increased its stake in shares of Healthpeak Properties by 3.1% in the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock worth $819,000 after acquiring an additional 1,415 shares during the period. Finally, Qube Research & Technologies Ltd acquired a new stake in shares of Healthpeak Properties in the second quarter worth $3,117,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

DOC opened at $19.85 on Thursday. The firm’s fifty day simple moving average is $17.66 and its two-hundred day simple moving average is $17.30. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The company has a market cap of $13.69 billion, a price-to-earnings ratio of 62.04, a PEG ratio of 2.54 and a beta of 1.00. Healthpeak Properties, Inc. has a 52-week low of $15.70 and a 52-week high of $20.27.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period last year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities analysts anticipate that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 15th will be paid a $0.1017 dividend. This represents a c) annualized dividend and a dividend yield of 6.1%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 381.25%.

Analyst Upgrades and Downgrades

Several analysts recently commented on DOC shares. Wells Fargo & Company restated a “positive” rating on shares of Healthpeak Properties in a research report on Tuesday, February 3rd. Evercore downgraded shares of Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price objective on the stock. in a report on Monday, May 11th. UBS Group increased their price objective on shares of Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a report on Wednesday, May 13th. Citigroup increased their price objective on shares of Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Finally, Argus downgraded shares of Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Five analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $19.23.

Insider Buying and Selling at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 0.23% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.